Pharmaceutical

AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer

The approval comes amid speculation that AstraZeneca CEO Pascal Soriot is considering delisting its UK stock market listing for the US.

Jul 5, 2025 - 06:00
AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer
The approval comes amid speculation that AstraZeneca CEO Pascal Soriot is considering delisting its UK stock market listing for the US.
Read the original article

Tags:

Previous Article

Modella AI and AstraZeneca link for cancer clinical development

Next Article

Big pharma braces for revenue headwinds as patent expiries loom

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: EU releases proposed pharma overhaul, cutting period of market exclusivity

STAT+: EU releases proposed pharma overhaul, cutting pe...

Apr 27, 2023

ESMO 2023: Mirati’s Krazati and immuno-oncology combo to shape first-line NSCLC

ESMO 2023: Mirati’s Krazati and immuno-oncology combo t...

Oct 23, 2023

STAT+: UnitedHealth used secret rules to restrict rehab care for seriously ill Medicare Advantage patients

STAT+: UnitedHealth used secret rules to restrict rehab...

Dec 29, 2023